RXi Shares Begin Public Trading as Company Sets Goals for 2008, 2009

Having finally been spun out of CytRx, RXi is now aiming to file its first investigational new drug application next year and ink its first industry partnership this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.